Paper11259636
Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities.
Baek SJ and 4 others. Mol Pharmacol, 2001. Cited by 342 papers, by iCite.
Cite this record
ConductScience Library. Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Papers, record 11259636. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11259636
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Apoptosis | Major topic |
| Colorectal Neoplasms | Major topic |
| Cyclooxygenase Inhibitors | Major topic |
| Cytokines | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Animals | |
| Anti-Inflammatory Agents, Non-Steroidal | |
| Cell Division | |
| Dose-Response Relationship, Drug | |
| Growth Differentiation Factor 15 | |
| Humans | |
| Male | |
| Mice | |
| Mice, Nude | |
| Molecular Sequence Data | |
| RNA, Messenger | |
| Transfection | |
| Transforming Growth Factor beta | |
| Tumor Cells, Cultured | |
| Tumor Stem Cell Assay | |
| Xenograft Model Antitumor Assays |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Z01ES010016 | NIH | NIH RePORTER | |||
| ZIAES010016 | NIH | NIH RePORTER |
Cited by164
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 342 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42602551 | Immunomodulatory functions of growth differentiation factor 15 in skin aging and inflammatory dermatoses. | Front Immunol | 2026 | https://conductscience.org/library/papers/42602551 | PubMed |
| 42559080 | Thyroid follicular cell-derived GDF15 attenuates inflammation and lipid dysregulation in Hashimoto's thyroiditis. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42559080 | PubMed |
| 41824793 | Context-Dependent Role of GDF15: GDF15+ Tumor-Associated Macrophages Suppress OSCC Progression by Enhancing Phagocytosis. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41824793 | PubMed |
| 40837873 | Emerging Roles of GDF15 in Metabolic and Cardiovascular Diseases. | Research (Wash D C) | 2025 | https://conductscience.org/library/papers/40837873 | PubMed |
| 40825850 | Metabolic Messenger: growth differentiation factor 15. | Nat Metab | 2025 | https://conductscience.org/library/papers/40825850 | PubMed |
| 40569532 | GDF15: An emerging disease target and biomarker of metabolic diseases. | J Endocrinol Invest | 2025 | https://conductscience.org/library/papers/40569532 | PubMed |
| 40399974 | Characterization of feline nonsteroidal anti-inflammatory drug activated gene-1 (fNAG-1) and its protective function in kidney cells. | BMC Vet Res | 2025 | https://conductscience.org/library/papers/40399974 | PubMed |
| 40316530 | NAG-1/GDF15 as a tumor suppressor in colorectal cancer: inhibition of β-catenin and NF-κB pathways via interaction with EpCAM. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/40316530 | PubMed |
| 39781722 | Molecular and Functional Significance of Growth Differentiation Factor-15: A Review on Cardiovascular-Kidney-Metabolic Biomarker. | Curr Cardiol Rev | 2025 | https://conductscience.org/library/papers/39781722 | PubMed |
| 39660078 | Vascular and inflammatory biomarkers of cardiovascular events in non-steroidal anti-inflammatory drug users. | Eur Heart J Open | 2024 | https://conductscience.org/library/papers/39660078 | PubMed |
| 39643709 | GDF15/MIC-1: a stress-induced immunosuppressive factor which promotes the aging process. | Biogerontology | 2024 | https://conductscience.org/library/papers/39643709 | PubMed |
| 39103698 | The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas. | EMBO Mol Med | 2024 | https://conductscience.org/library/papers/39103698 | PubMed |
| 39000420 | Macrophages as a Source and Target of GDF-15. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39000420 | PubMed |
| 38965822 | Growth differentiation factor 15 is not modified after weight loss induced by liraglutide in South Asians and Europids with type 2 diabetes mellitus. | Exp Physiol | 2024 | https://conductscience.org/library/papers/38965822 | PubMed |
| 38911292 | GDF15: Immunomodulatory Role in Hepatocellular Carcinoma Pathogenesis and Therapeutic Implications. | J Hepatocell Carcinoma | 2024 | https://conductscience.org/library/papers/38911292 | PubMed |
| 38892145 | GDF15, an Emerging Player in Renal Physiology and Pathophysiology. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38892145 | PubMed |
| 38342006 | GPX3 supports ovarian cancer tumor progression in vivo and promotes expression of GDF15. | Gynecol Oncol | 2024 | https://conductscience.org/library/papers/38342006 | PubMed |
| 37749926 | NAG-1/GDF-15 Transgenic Female Mouse Shows Delayed Peak Period of the Second Phase Nociception in Formalin-induced Inflammatory Pain. | Exp Neurobiol | 2023 | https://conductscience.org/library/papers/37749926 | PubMed |
| 37637689 | Recent progress in understanding mitokines as diagnostic and therapeutic targets in hepatocellular carcinoma. | World J Clin Cases | 2023 | https://conductscience.org/library/papers/37637689 | PubMed |
| 37286811 | Physiological activation of human and mouse bitter taste receptors by bile acids. | Commun Biol | 2023 | https://conductscience.org/library/papers/37286811 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GDF15 | 9518 | Swiss-Prot's references | https://conductscience.org/library/genes/9518 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GENBANK | AF173860 |
Source GENBANK
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11259636
GET https://conductscience.org/api/papers/v1/11259636/cited_by?page=2